Literature DB >> 7839913

Plasma progesterone, estradiol-17 beta and testosterone in maternal and cord blood, and maternal human chorionic gonadotropin at parturition.

O Adeyemo1, H Jeyakumar.   

Abstract

To understand the endocrine control of normal parturition in man and interactions of foetal and maternal hormones involved, it is desirable to estimate the hormone levels in the maternal and foetal blood around parturition time. Blood was obtained from the umbilical vessels of 22 male and 30 female neonates and the antecubital veins of their mothers during labour at term. The maternal and neonatal plasma levels of progesterone (P), testosterone (T) and estradiol-17 beta (E2) and maternal plasma levels of human chorionic gonadotrophin (hCG) were determined by radioimmunoassay (RIA). The effect of the foetal sex on the maternal hormones at term was also evaluated. Mean values, with the standard errors of means, of plasma, P, T and E2 in cord blood were 5.3 +/- 0.3, 8.4 +/- 1.2 and 5.0 +/- 0.3 ng/ml, respectively; in the maternal plasma the values were 18.2 +/- 1.2, 1.2 +/- 0.1 and 4.3 +/- 0.4 ng/ml, respectively. The mean T level was significantly higher in cord than in maternal blood, while P was significantly higher in the maternal than in cord blood. The plasma concentrations of P, T and E2 in the mothers delivering male babies were 16.9 +/- 2.2, 1.2 +/- 0.4 and 4.5 +/- 0.7 ng/ml, respectively; in those delivering female babies, the levels were 16.1 +/- 2.4, 1.1 +/- 0.1 and 4.3 +/- 0.4 ng/ml, respectively. Mean plasma levels of hCG in the women was 0.9 +/- 0.1 microgram/ml with no significant difference between the values in the mothers of male and female babies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7839913

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  14 in total

1.  Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages.

Authors:  Amy J Murphy; Paul M Guyre; Patricia A Pioli
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

2.  Choline: clinical nutrigenetic/nutrigenomic approaches for identification of functions and dietary requirements.

Authors:  Steven H Zeisel
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-06

Review 3.  Choline and betaine in health and disease.

Authors:  Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

Review 4.  Choline: clinical nutrigenetic/nutrigenomic approaches for identification of functions and dietary requirements.

Authors:  Steven H Zeisel
Journal:  World Rev Nutr Diet       Date:  2010-04-30       Impact factor: 0.575

Review 5.  The fetal origins of memory: the role of dietary choline in optimal brain development.

Authors:  Steven H Zeisel
Journal:  J Pediatr       Date:  2006-11       Impact factor: 4.406

Review 6.  What can development teach us about menopause?

Authors:  Margaret M McCarthy
Journal:  Brain Res       Date:  2010-12-04       Impact factor: 3.252

Review 7.  Genetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models.

Authors:  Steven H Zeisel
Journal:  Brain Res       Date:  2008-09-03       Impact factor: 3.252

8.  Estradiol increases guanosine 5'-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5'-monophosphate response element binding protein.

Authors:  Xutong Sun; Sanjiv Kumar; Jing Tian; Stephen M Black
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

Review 9.  Gene response elements, genetic polymorphisms and epigenetics influence the human dietary requirement for choline.

Authors:  Steven H Zeisel
Journal:  IUBMB Life       Date:  2007-06       Impact factor: 3.885

10.  Estradiol regulates expression of estrogen receptor ERalpha46 in human macrophages.

Authors:  Amy J Murphy; Paul M Guyre; Charles R Wira; Patricia A Pioli
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.